Osmetech Molecular Diagnostics

Osmetech Molecular Diagnostics — FDA 510(k) Submissions

Osmetech Molecular Diagnostics has submitted 3 FDA 510(k) premarket notifications since 2008, of which 3 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Cytochrome P450 2c9 (cyp450 2c9) Drug Metabolizing Enzyme Genotyping System, System, Cystic Fibrosis Transmembrane Conductance Regulator, Gene Mutation Detection, Test, Factor V Leiden Mutations, Genomic Dna Pcr . Use the specialty filter in the sidebar to narrow results.